JP2021502809A - 免疫細胞、特に単球性骨髄由来抑制細胞(mMDSC)の同定のためのエピジェネティックマーカーとしてのERGIC1 - Google Patents

免疫細胞、特に単球性骨髄由来抑制細胞(mMDSC)の同定のためのエピジェネティックマーカーとしてのERGIC1 Download PDF

Info

Publication number
JP2021502809A
JP2021502809A JP2020524841A JP2020524841A JP2021502809A JP 2021502809 A JP2021502809 A JP 2021502809A JP 2020524841 A JP2020524841 A JP 2020524841A JP 2020524841 A JP2020524841 A JP 2020524841A JP 2021502809 A JP2021502809 A JP 2021502809A
Authority
JP
Japan
Prior art keywords
cells
cpg
mmdsc
seq
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020524841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502809A5 (https=
Inventor
オレク,スフェン
Original Assignee
エピオンティス ゲーエムベーハー
エピオンティス ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エピオンティス ゲーエムベーハー, エピオンティス ゲーエムベーハー filed Critical エピオンティス ゲーエムベーハー
Publication of JP2021502809A publication Critical patent/JP2021502809A/ja
Publication of JP2021502809A5 publication Critical patent/JP2021502809A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2020524841A 2017-11-09 2018-11-06 免疫細胞、特に単球性骨髄由来抑制細胞(mMDSC)の同定のためのエピジェネティックマーカーとしてのERGIC1 Pending JP2021502809A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017126248.2 2017-11-09
DE102017126248.2A DE102017126248B4 (de) 2017-11-09 2017-11-09 ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs)
PCT/EP2018/080235 WO2019091942A1 (en) 2017-11-09 2018-11-06 ERGIC1 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF IMMUNE CELLS, IN PARTICULAR MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELLS (mMDSCs)

Publications (2)

Publication Number Publication Date
JP2021502809A true JP2021502809A (ja) 2021-02-04
JP2021502809A5 JP2021502809A5 (https=) 2021-08-19

Family

ID=64184067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524841A Pending JP2021502809A (ja) 2017-11-09 2018-11-06 免疫細胞、特に単球性骨髄由来抑制細胞(mMDSC)の同定のためのエピジェネティックマーカーとしてのERGIC1

Country Status (7)

Country Link
US (1) US11976327B2 (https=)
EP (1) EP3669005B1 (https=)
JP (1) JP2021502809A (https=)
CN (1) CN111315896A (https=)
AU (1) AU2018364335A1 (https=)
DE (1) DE102017126248B4 (https=)
WO (1) WO2019091942A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016515397A (ja) * 2013-04-19 2016-05-30 エピオンティス ゲーエムベーハー 生体サンプルにおける定量的細胞組成を特定する方法
JP2017511142A (ja) * 2014-04-14 2017-04-20 イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド Dnaの組織または細胞起源を決定するための方法およびキット

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2869295A1 (en) 2011-05-25 2012-11-29 Brown University Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016515397A (ja) * 2013-04-19 2016-05-30 エピオンティス ゲーエムベーハー 生体サンプルにおける定量的細胞組成を特定する方法
JP2017511142A (ja) * 2014-04-14 2017-04-20 イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド Dnaの組織または細胞起源を決定するための方法およびキット

Also Published As

Publication number Publication date
DE102017126248B4 (de) 2019-10-17
US20200347453A1 (en) 2020-11-05
CA3082261A1 (en) 2019-05-16
DE102017126248A1 (de) 2019-05-09
AU2018364335A1 (en) 2020-05-28
CN111315896A (zh) 2020-06-19
WO2019091942A1 (en) 2019-05-16
EP3669005B1 (en) 2026-03-04
US11976327B2 (en) 2024-05-07
EP3669005A1 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
EP3353318B1 (en) Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells
EP3353319B1 (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes
CN108026577B (zh) Mvd作为用于鉴定免疫细胞特别是cd56+nk细胞的表观遗传标志物
JP2021501574A (ja) 免疫細胞、特に好塩基性顆粒球の同定のためのエピジェネティックマーカーとしてのmcc
CN111278988A (zh) 作为用于鉴定免疫细胞,特别是初始cd8+ t细胞的表观遗传标志物的内皮唾液酸蛋白(cd248)
EP3669001B1 (en) Amplicon region as epigenetic marker for the identification of non-classical monocytes
CA3082261C (en) Ergic1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mmdscs)
JP2021502809A (ja) 免疫細胞、特に単球性骨髄由来抑制細胞(mMDSC)の同定のためのエピジェネティックマーカーとしてのERGIC1
CA2969370A1 (en) Epigenetic method for the identification of follicular t-helper-(tfh-) cells
CA3080060C (en) Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells
EP3669003B1 (en) Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells
CA2999611C (en) Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells
CN112236531A (zh) 作为用于鉴定炎性免疫细胞,特别是cd8+记忆t细胞的表观遗传标志物的cxcr3
HK1257582B (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210708

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220630

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230830